Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edimara S Reis

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Molecular Cancer Research : MCR|August 19, 2016
High-Fat Diet-Induced Complement Activation Mediates Intestinal Inflammation and Neoplasia, Independent of ObesityStephanie K Doerner, Edimara S Reis, Elaine S Leung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 12, 2016
Systems Analysis of the Complement-Induced Priming Phase of Liver RegenerationJun S Min, Robert A DeAngelis, Edimara S Reis, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 20, 2016
Method development and validation for the quantitation of the complement inhibitor Cp40 in human and cynomolgus monkey plasma by UPLC-ESI-MSAlexandra Primikyri, Malvina Papanastasiou, Yiannis Sarigiannis, et al.
Thrombosis and Haemostasis|July 1, 2018
Novel Immunoassay for Complement Activation by PF4/Heparin ComplexesSanjay Khandelwal, Alexandra M Johnson, Jian Liu, et al.
Nature Communications|August 15, 2013
Complement anaphylatoxin C3a is a potent inducer of embryonic chick retina regenerationTracy Haynes, Agustin Luz-Madrigal, Edimara S Reis, et al.
Clinical Immunology (Orlando, Fla.)|November 26, 2018
Taming hemodialysis-induced inflammation: Are complement C3 inhibitors a viable option?Dimitrios C Mastellos, Edimara S Reis, Ali-Reza Biglarnia, et al.
Molecular Therapy. Methods & Clinical Development|September 8, 2017
Safety and Efficacy of the Complement Inhibitor AMY-101 in a Natural Model of Periodontitis in Non-human PrimatesTetsuhiro Kajikawa, Ruel A Briones, Ranillo R G Resuello, et al.
Haematologica|June 8, 2019
Complement C3 inhibition by compstatin Cp40 prevents intra- and extravascular hemolysis of red blood cellsInge Baas, Laura Delvasto-Nuñez, Peter Ligthart, et al.
American Journal of Physiology. Renal Physiology|January 6, 2017
Pericytes and immune cells contribute to complement activation in tubulointerstitial fibrosisSandhya Xavier, Ranjit K Sahu, Susan G Landes, et al.
Immunobiology|July 17, 2012
New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic propertiesHongchang Qu, Daniel Ricklin, Hongjun Bai, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Molecular Cancer Research : MCR|August 19, 2016
High-Fat Diet-Induced Complement Activation Mediates Intestinal Inflammation and Neoplasia, Independent of ObesityStephanie K Doerner, Edimara S Reis, Elaine S Leung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 12, 2016
Systems Analysis of the Complement-Induced Priming Phase of Liver RegenerationJun S Min, Robert A DeAngelis, Edimara S Reis, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 20, 2016
Method development and validation for the quantitation of the complement inhibitor Cp40 in human and cynomolgus monkey plasma by UPLC-ESI-MSAlexandra Primikyri, Malvina Papanastasiou, Yiannis Sarigiannis, et al.
Thrombosis and Haemostasis|July 1, 2018
Novel Immunoassay for Complement Activation by PF4/Heparin ComplexesSanjay Khandelwal, Alexandra M Johnson, Jian Liu, et al.
Nature Communications|August 15, 2013
Complement anaphylatoxin C3a is a potent inducer of embryonic chick retina regenerationTracy Haynes, Agustin Luz-Madrigal, Edimara S Reis, et al.
Clinical Immunology (Orlando, Fla.)|November 26, 2018
Taming hemodialysis-induced inflammation: Are complement C3 inhibitors a viable option?Dimitrios C Mastellos, Edimara S Reis, Ali-Reza Biglarnia, et al.
Molecular Therapy. Methods & Clinical Development|September 8, 2017
Safety and Efficacy of the Complement Inhibitor AMY-101 in a Natural Model of Periodontitis in Non-human PrimatesTetsuhiro Kajikawa, Ruel A Briones, Ranillo R G Resuello, et al.
Haematologica|June 8, 2019
Complement C3 inhibition by compstatin Cp40 prevents intra- and extravascular hemolysis of red blood cellsInge Baas, Laura Delvasto-Nuñez, Peter Ligthart, et al.
American Journal of Physiology. Renal Physiology|January 6, 2017
Pericytes and immune cells contribute to complement activation in tubulointerstitial fibrosisSandhya Xavier, Ranjit K Sahu, Susan G Landes, et al.
Immunobiology|July 17, 2012
New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic propertiesHongchang Qu, Daniel Ricklin, Hongjun Bai, et al.
Pageof 6